134 related articles for article (PubMed ID: 28278149)
21. The economic burden of bronchiectasis - known and unknown: a systematic review.
Goeminne PC; Hernandez F; Diel R; Filonenko A; Hughes R; Juelich F; Solomon GM; Upton A; Wichmann K; Xu W; Chalmers JD
BMC Pulm Med; 2019 Feb; 19(1):54. PubMed ID: 30819166
[TBL] [Abstract][Full Text] [Related]
22. The cost of persistent asthma in Europe: an international population-based study in adults.
Accordini S; Corsico AG; Braggion M; Gerbase MW; Gislason D; Gulsvik A; Heinrich J; Janson C; Jarvis D; Jõgi R; Pin I; Schoefer Y; Bugiani M; Cazzoletti L; Cerveri I; Marcon A; de Marco R
Int Arch Allergy Immunol; 2013; 160(1):93-101. PubMed ID: 22948386
[TBL] [Abstract][Full Text] [Related]
23. [Cost-of-illness study of asthma in Korea: estimated from the Korea National Health insurance claims database].
Park CS; Kang HY; Kwon I; Kang DR; Jung HY
J Prev Med Public Health; 2006 Sep; 39(5):397-403. PubMed ID: 17076180
[TBL] [Abstract][Full Text] [Related]
24. Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain.
Vennera Mdel C; Valero A; Uría E; Forné C; Picado C
Clin Drug Investig; 2016 Jul; 36(7):567-78. PubMed ID: 27142072
[TBL] [Abstract][Full Text] [Related]
25. A national estimate of the economic costs of asthma.
Smith DH; Malone DC; Lawson KA; Okamoto LJ; Battista C; Saunders WB
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):787-93. PubMed ID: 9309994
[TBL] [Abstract][Full Text] [Related]
26. Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study.
Schramm B; Ehlken B; Smala A; Quednau K; Berger K; Nowak D
Eur Respir J; 2003 Jan; 21(1):116-22. PubMed ID: 12570119
[TBL] [Abstract][Full Text] [Related]
27. Poor control increases the economic cost of asthma. A multicentre population-based study.
Accordini S; Bugiani M; Arossa W; Gerzeli S; Marinoni A; Olivieri M; Pirina P; Carrozzi L; Dallari R; De Togni A; de Marco R
Int Arch Allergy Immunol; 2006; 141(2):189-98. PubMed ID: 16899987
[TBL] [Abstract][Full Text] [Related]
28. Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma.
Johansson G; Andreasson EB; Larsson PE; Vogelmeier CF
Pharmacoeconomics; 2006; 24(7):695-708. PubMed ID: 16802845
[TBL] [Abstract][Full Text] [Related]
29. Healthcare costs and resource utilization of asthma in Germany: a claims data analysis.
Jacob C; Bechtel B; Engel S; Kardos P; Linder R; Braun S; Greiner W
Eur J Health Econ; 2016 Mar; 17(2):195-201. PubMed ID: 25716136
[TBL] [Abstract][Full Text] [Related]
30. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.
Cruess AF; Zlateva G; Xu X; Soubrane G; Pauleikhoff D; Lotery A; Mones J; Buggage R; Schaefer C; Knight T; Goss TF
Pharmacoeconomics; 2008; 26(1):57-73. PubMed ID: 18088159
[TBL] [Abstract][Full Text] [Related]
31. Healthcare resource utilization, expenditures, and productivity in patients with asthma with and without allergies.
Sullivan PW; Lanz MJ; Ghushchyan VH; Kavati A; LeCocq J; Ortiz B; Maselli DJ
J Asthma; 2020 Sep; 57(9):959-967. PubMed ID: 31264894
[No Abstract] [Full Text] [Related]
32. Incremental Health Care Expenditure of Chronic Cutaneous Ulcers in the United States.
Tripathi R; Knusel KD; Ezaldein HH; Honaker JS; Bordeaux JS; Scott JF
JAMA Dermatol; 2019 Jun; 155(6):694-699. PubMed ID: 30892572
[TBL] [Abstract][Full Text] [Related]
33. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.
Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():19-29. PubMed ID: 27038625
[TBL] [Abstract][Full Text] [Related]
34. The Economic Burden of Asthma in Greece: A Cross-Sectional Study.
Vellopoulou K; Bakakos P; Loukides S; Maniadakis N; Kourlaba G
Appl Health Econ Health Policy; 2019 Oct; 17(5):629-640. PubMed ID: 30997609
[TBL] [Abstract][Full Text] [Related]
35. The Cost of Asthma Treatment in Phramongkutlao Hospital: Population-Based Study in Adults.
Boonpiyathad T; Yimsawad S; Sangasapaviriya A
J Med Assoc Thai; 2016 Jan; 99(1):51-7. PubMed ID: 27455824
[TBL] [Abstract][Full Text] [Related]
36. The economic and quality-of-life burden of Crohn's disease in Europe and the United States, 2000 to 2013: a systematic review.
Floyd DN; Langham S; Séverac HC; Levesque BG
Dig Dis Sci; 2015 Feb; 60(2):299-312. PubMed ID: 25258034
[TBL] [Abstract][Full Text] [Related]
37. Cost of asthma in children: A nationwide, population-based, cost-of-illness study.
Ferreira de Magalhães M; Amaral R; Pereira AM; Sá-Sousa A; Azevedo I; Azevedo LF; Fonseca JA
Pediatr Allergy Immunol; 2017 Nov; 28(7):683-691. PubMed ID: 28815837
[TBL] [Abstract][Full Text] [Related]
38. [The cost of schizophrenia: a literature review].
Charrier N; Chevreul K; Durand-Zaleski I
Encephale; 2013 May; 39 Suppl 1():S49-56. PubMed ID: 23351935
[TBL] [Abstract][Full Text] [Related]
39. The socioeconomic costs of mental illness in Spain.
Oliva-Moreno J; López-Bastida J; Montejo-González AL; Osuna-Guerrero R; Duque-González B
Eur J Health Econ; 2009 Oct; 10(4):361-9. PubMed ID: 19031056
[TBL] [Abstract][Full Text] [Related]
40. Direct health care costs of occupational asthma in Spain: an estimation from 2008.
García Gómez M; Urbanos Garrido R; Castañeda López R; López Menduiña P
Arch Bronconeumol; 2012 Oct; 48(10):355-61. PubMed ID: 22705259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
